Skip to main content

Asset Sales

Unique Asset Sale Issues in Health Care

This panel will identify the unique issues that come into play in health care asset sales, from hospitals to senior living facilities. The panelists will address closing challenges, regulatory issues, HIPPA/privacy issues, Opco/Propco issues and much more.
1 hour 9 minutes 14 seconds

Hot Topics in Real Estate Cases

This panel will discuss a broad range of topics that arise in real estate-driven bankruptcy cases, including issues for landlords with respect to post-petition lease restructuring and the disposition of personal property by debtor tenants; determining the appropriate cramdown interest rates for different real estate sectors in a volatile interest rate environment; special issues implicated in bankruptcies of hospitality-focused real properties; and the particular challenges involved in restructuring partially developed properties.
1 hour 13 minutes 6 seconds

Supreme Court Review: Recent Decisions and Their Potential Implications for Bankruptcy Lawyers

Do you ever wonder what a particular Supreme Court decision means for you and your practice? This panel will discuss the Supreme Court’s general approach to deciding cases, including bankruptcy cases, and what those decisions mean for the bankruptcy and larger legal community. The panelists will use decisions from last term (as well as those to be argued this term) to help attendees better understand the decisions, how they might influence lower court decisions, and what it all means for those subjected to their decisions.
1 hour 19 minutes 11 seconds

The Brave New World of Asset Sales and the Increased Role of Unsecured Creditors

This panel takes a fresh look at the latest categories and buyers of asset sales under § 363, and the increased influence that unsecured creditors are exerting over those sales. The panelists discuss recent noteworthy successful and failed sales, including Vice Media, Vital Pharmaceuticals, Inc., Celsius Network, LedgerX and Voyager.

ABI Live: Change of Control via 363 Sale vs. Plan of Reorganization

The first two parts of this three-part webinar series focused on key topics associated with sales that take place in chapter 11 bankruptcies, and addressed executory contract rejection, the role of customers in chapter 11 bankruptcy proceedings, and change of control via a § 363 sale vs. a plan of reorganization. In this third and last session, the panelists will explore the complexities of sales in chapter 11 bankruptcy with a focus on two common methods of selling a business: plans of reorganization and § 363 sales. The panelists will explore the pros and cons of each method from the perspectives of customers, creditors and debtors, and will provide insights into when each should be utilized. Our experts will compare plans of reorganization to § 363 sales, outlining key differences, timelines, the parties involved and the level of court involvement, and will provide guidance on when to choose a plan versus a § 363 sale and the potential impact of each. Attendees will better understand the options available for selling in a chapter 11 bankruptcy, and the factors to consider when choosing between a plan of reorganization and a § 363 sale. Join us to gain insights into the complexities of chapter 11 sales and how to navigate them successfully.
31 minutes 20 seconds

Sales: § 363 Developments

This session will cover recent approaches to sales, recent trends in sale cases, the roles of the various constituents in sale cases, biopharmaceutical sales, lease issues and much more.
1 hour 3 minutes 33 seconds

Corporate Valuation: Before, During and Post-Pandemic

For nearly 100 years, we have not experienced a shock to the economy where large numbers of industries exhibited disastrous declines in revenues resulting from a pandemic. Frankly, none of us were equipped with readily available valuation frameworks to handle such shocking changes in cash-flow projections, discount rates, the ‘appropriate’ use of comparable companies and the relevant transactions to be used in the M&A comparable method. This panel discussion will present the main valuation parameters that have been affected by the COVID-19 pandemic and the associated legal and experts’ battles, mostly during and post-pandemic.
59 minutes 19 seconds